What is MOC?
Mucinous ovarian cancer is a rare epithelial tumor filled with mucus. It behaves differently from more common ovarian cancers and represents roughly 2.4% to 3% of epithelial cases.
ALIVE.
MOC Awareness / Facts
Understanding
A rare and distinct ovarian cancer that often affects younger people and needs specialized diagnosis, treatment, and research.
Mucinous ovarian cancer is a rare epithelial tumor filled with mucus. It behaves differently from more common ovarian cancers and represents roughly 2.4% to 3% of epithelial cases.
MOC tends to affect younger people. The average age at diagnosis is 45, and it is frequently found in people under 40.
Tumors can become extremely large and may feel like a lump on one side of the abdomen. Symptoms include bloating, pelvic pain, weight gain, and feeling full quickly.
CA-125 may be normal or only mildly elevated, while CEA or CA19-9 may be raised. MOC is not linked to the usual family-history risk pattern. Smoking is the only currently identified risk factor; KRAS and TP53 mutations are common.
About 80% of mucinous tumors found in the ovary are metastatic, often originating in the gastrointestinal tract, pancreas, or appendix. Rigorous pathology and tissue staining are needed to distinguish them from primary MOC.
Large tumors often cause earlier symptoms, so most cases are found at stage 1. Surgery is the primary treatment and can sometimes preserve fertility. Advanced MOC is difficult to treat because it is less sensitive to standard platinum chemotherapy.
Its rarity and treatment resistance make dedicated research urgent. There have been no successful clinical trials exclusively for MOC, leaving major gaps in evidence for advanced disease.
Help with appointments, meals, transport, or everyday needs. Support rare ovarian cancer advocacy groups and research focused on better treatments.